Business Context and Reporting Period
Company: Abbott Laboratories
Filing Type: Form 8-K (Current Report)
Date of Report: April 21, 2010
Reporting Period: First Quarter 2010
This filing announces the results of operations for the first quarter of 2010. The detailed financial data is contained in a press release furnished as Exhibit 99.1 and incorporated by reference.
Key Financial Metrics
The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are located in the referenced press release (Exhibit 99.1).
The company utilizes non-GAAP financial measures to evaluate ongoing business performance, specifically:
- Net earnings excluding specified items.
- Diluted earnings per common share excluding specified items.
Adjustments are made for unusual or unpredictable factors including acquisition-related costs, currency devaluations, legislative reforms, litigation settlements, cost reduction initiatives, and product launch costs.
Material Changes
The filing text does not explicitly detail material changes versus the prior comparable period. Investors must refer to the incorporated press release for specific year-over-year comparisons.
Guidance, Outlook, and Risks
Management Commentary: Management believes non-GAAP measures provide useful information for evaluating ongoing performance and are used internally to monitor business results. However, the company cautions that these measures should be considered in addition to, and not as a substitute for, GAAP financial measures.
Risks and Contingencies: The filing identifies specific factors that impact financial results and are excluded from non-GAAP measures, including:
- Currency devaluations.
- Legislative reforms.
- Litigation settlements.
- Acquisition-related costs.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q1 2010 revenue, net earnings, and EPS figures.
- Compare GAAP results against non-GAAP results to understand the impact of excluded items.
- Verify the specific dollar amounts attributed to currency devaluations and legislative reforms.
- Check for any updated full-year guidance provided in the press release.